Effects of Psychological Stress on the Stratum Corneum
心理压力对角质层的影响
基本信息
- 批准号:7002256
- 负责人:
- 金额:$ 29.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-01 至 2008-12-31
- 项目状态:已结题
- 来源:
- 关键词:binding proteinsclinical researchendopeptidasesenzyme activityfatty acid metabolismgas chromatography mass spectrometrygel mobility shift assayglucocorticoidshuman subjectintercellular connectionlaboratory mouselipid metabolismmembrane permeabilitypharmacokineticspsychological stressorskinskin absorptionskin pharmacologysteroid hormone biosynthesistopical drug application
项目摘要
DESCRIPTION (provided by applicant):
Although psychological stress (PS) is well recognized to provoke and exacerbate cutaneous disorders the mechanism(s) for this are unknown. Recently, we have shown that permeability barrier homeostasis is impaired in animal models of PS and in humans with PS. PS increases serum glucocorticoid (GC) levels and inhibition of GC action prevents the barrier abnormality. Moreover, GC treatment similarly produces an abnormality in barrier function due to the decreased production and secretion of lamellar bodies (LB), which can be explained by GC inhibiting the epidermal synthesis of cholesterol, fatty acids, and ceramides. Topical lipids correct the barrier abnormality directly demonstrating that the inhibition of epidermal lipid synthesis is a major factor accounting for the abnormal barrier. GC treatment also compromises SC integrity and cohesion due to a decrease corneodesmosomes (CD) density. Topical lipids improve the defect in SC integrity and cohesion indicating that a deficiency of lipids also plays a role in mediating these abnormalities. Hypothesis: PS inhibits barrier homeostasis by stimulating GC production, which inhibits epidermal lipid synthesis resulting in a decrease in LB formation/secretion leading to impaired barrier homeostasis. Additionally, the PS/GC induced decrease in lamellar membranes in the SC increases protease activity reducing CD density, thereby decreasing SC integrity and cohesion. Correction of the lipid deficiency ameliorates the harmful consequences of PS and GC treatment on the epidermis. Aim 1- To determine if PS, by increasing GC production, a) impairs barrier homeostasis by decreasing epidermal lipid synthesis and LB formation/ secretion and b) compromises SC integrity and cohesion by decreasing CD density in the SC. Aim 2- To determine the biochemical basis and molecular mechanisms responsible for the PS/GC induced inhibition of epidermal lipid synthesis. Aim 3-To determine the mechanisms for the abnormality in SC integrity and cohesion, we will assess the effects of PS/GC on both the formation and degradation of CD. Aim 4: To determine if the abnormalities in permeability barrier homeostasis and SC integrity/ cohesion induced by GC treatment in humans, are due to the inhibition of epidermal lipid synthesis.
描述(由申请人提供):
虽然心理应激(PS)被公认为引起和加重皮肤疾病,但其机制尚不清楚。最近,我们已经表明,渗透屏障稳态受损的动物模型的PS和PS的人。PS增加血清糖皮质激素(GC)水平,抑制GC作用可防止屏障异常。此外,GC治疗类似地由于板层体(LB)的产生和分泌减少而产生屏障功能异常,这可以通过GC抑制胆固醇、脂肪酸和神经酰胺的表皮合成来解释。局部脂质直接纠正屏障异常,表明表皮脂质合成的抑制是导致屏障异常的主要因素。GC处理还由于角蛋白桥粒(CD)密度降低而损害SC完整性和凝聚力。局部脂质改善了SC完整性和凝聚力的缺陷,表明脂质的缺乏也在介导这些异常中起作用。假设:PS通过刺激GC产生来抑制屏障稳态,GC抑制表皮脂质合成,导致LB形成/分泌减少,从而导致屏障稳态受损。此外,PS/GC诱导的SC中层状膜的减少增加了蛋白酶活性,降低了CD密度,从而降低了SC的完整性和凝聚力。脂质缺乏的纠正改善了PS和GC治疗对表皮的有害后果。目的1-确定PS是否通过增加GC产生,a)通过减少表皮脂质合成和LB形成/分泌损害屏障稳态,和B)通过降低SC中的CD密度损害SC完整性和凝聚力。目的2-确定负责PS/GC诱导的表皮脂质合成抑制的生化基础和分子机制。目的3-为了确定SC完整性和凝聚力异常的机制,我们将评估PS/GC对CD形成和降解的影响。目标4:确定GC处理诱导的人体渗透性屏障稳态和SC完整性/凝聚力异常是否是由于抑制表皮脂质合成所致。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH R FEINGOLD其他文献
KENNETH R FEINGOLD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH R FEINGOLD', 18)}}的其他基金
Effects of Psychological Stress on the Stratum Corneum
心理压力对角质层的影响
- 批准号:
6729393 - 财政年份:2004
- 资助金额:
$ 29.32万 - 项目类别:
PPARs and LXR Regulate Epidermal Differentiation
PPAR 和 LXR 调节表皮分化
- 批准号:
6719880 - 财政年份:2004
- 资助金额:
$ 29.32万 - 项目类别:
Effects of Psychological Stress on the Stratum Corneum
心理压力对角质层的影响
- 批准号:
6879692 - 财政年份:2004
- 资助金额:
$ 29.32万 - 项目类别:
PPARs and LXR Regulate Epidermal Differentiation
PPAR 和 LXR 调节表皮分化
- 批准号:
7087047 - 财政年份:2004
- 资助金额:
$ 29.32万 - 项目类别:
PPARs and LXR Regulate Epidermal Differentiation
PPAR 和 LXR 调节表皮分化
- 批准号:
6935210 - 财政年份:2004
- 资助金额:
$ 29.32万 - 项目类别:
Effects of Psychological Stress on the Stratum Corneum
心理压力对角质层的影响
- 批准号:
7169804 - 财政年份:2004
- 资助金额:
$ 29.32万 - 项目类别:
Effects of Psychological Stress on the Stratum Corneum
心理压力对角质层的影响
- 批准号:
7385070 - 财政年份:2004
- 资助金额:
$ 29.32万 - 项目类别:
EFFECT OF PPAR-ALPHA ACTIVATORS ON KERATINOCYTE DIFFERENTIATIION
PPAR-α 激活剂对角质形成细胞分化的影响
- 批准号:
6345964 - 财政年份:2000
- 资助金额:
$ 29.32万 - 项目类别:
EFFECT OF PPAR-ALPHA ACTIVATORS ON KERATINOCYTE DIFFERENTIATIION
PPAR-α 激活剂对角质形成细胞分化的影响
- 批准号:
6197176 - 财政年份:1999
- 资助金额:
$ 29.32万 - 项目类别:
RELATIONSHIP OF PERMEABILITY BARRIER FUNCTION AND EPIDERMAL CYTOKINE PRODUCTION
通透性屏障功能与表皮细胞因子产生的关系
- 批准号:
6100483 - 财政年份:1997
- 资助金额:
$ 29.32万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 29.32万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 29.32万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 29.32万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 29.32万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 29.32万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 29.32万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 29.32万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 29.32万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 29.32万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 29.32万 - 项目类别: